Qsemble Capital Management’s Repligen RGEN Stock Holding History

Qsemble Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,728	Closed	-$611K	–	592
2025 Q4	$611K	Buy	3,728 +291	+8%	+$45.6K	0.05%	350
2025 Q3	$459K	Sell	3,437 -434	-11%	-$52.7K	0.05%	340
2025 Q2	$481K	Buy	+3,871	New	+$493K	0.05%	326
2024 Q3	–	Sell	-1,853	Closed	-$234K	–	528
2024 Q2	$234K	Buy	+1,853	New	+$290K	0.04%	381
2024 Q1	–	Sell	-2,275	Closed	-$409K	–	512
2023 Q4	$409K	Buy	+2,275	New	+$354K	0.1%	263
2023 Q3	–	Sell	-2,800	Closed	-$396K	–	396
2023 Q2	$396K	Buy	+2,800	New	+$449K	0.28%	129

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Qsemble Capital Management's RGEN Position: Q1 2026 in Review

Qsemble Capital Management sold out of Repligen (RGEN) in Q1 2026, closing a stake of 3,728 shares — an estimated $611K sold.

Qsemble Capital Management first reported a position in RGEN in Q2 2023 and held it in 6 quarters. The position peaked at $611K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

Qsemble Capital Management reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
Qsemble Capital Management sold 3,728 Repligen shares in Q1 2026, an estimated $611K.
Qsemble Capital Management first reported a position in Repligen in Q2 2023 and held it in 6 quarters.
Qsemble Capital Management's Repligen position peaked at $611K in Q4 2025.
441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Qsemble Capital Management's 13F filing for Q1 2026, filed 7 May 2026.